Abstract
Positron emission tomography (PET) radioligands (radioactively labelled tracer compounds) are extremely useful for in vivo characterization of central nervous system drug candidates, neurodegenerative diseases and numerous oncology targets1. Both tritium and carbon-11 radioisotopologues are generally necessary for in vitro and in vivo characterization of radioligands2, yet there exist few radiolabelling protocols for the synthesis of either, inhibiting the development of PET radioligands. The synthesis of such radioligands also needs to be very rapid owing to the short half-life of carbon-11. Here we report a versatile and rapid metallaphotoredox-catalysed method for late-stage installation of both tritium and carbon-11 into the desired compounds via methylation of pharmaceutical precursors bearing aryl and alkyl bromides. Methyl groups are among the most prevalent structural elements found in bioactive molecules, and so this synthetic approach simplifies the discovery of radioligands. To demonstrate the breadth of applicability of this technique, we perform rapid synthesis of 20 tritiated and 10 carbon-11-labelled complex pharmaceuticals and PET radioligands, including a one-step radiosynthesis of the clinically used compounds [11C]UCB-J and [11C]PHNO. We further outline the direct utility of this protocol for preclinical PET imaging and its translation to automated radiosynthesis for routine radiotracer production in human clinical imaging. We also demonstrate this protocol for the installation of other diverse and pharmaceutically useful isotopes, including carbon-14, carbon-13 and deuterium.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Radiochemistry for positron emission tomography
Nature Communications Open Access 05 June 2023
-
Recyclable cooperative catalyst for accelerated hydroaminomethylation of hindered amines in a continuous segmented flow reactor
Nature Communications Open Access 04 May 2022
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry Open Access 18 March 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




Data availability
The data supporting the findings of this study are available within the paper and its Supplementary Information.
References
Ametamey, S. M., Honer, M. & Schubiger, P. A. Molecular imaging with PET. Chem. Rev. 108, 1501–1516 (2008).
Patel, S. & Gibson, R. In vivo site-directed radiotracers: a mini-review. Nucl. Med. Biol. 35, 805–815 (2008).
Atzrodt, J., Derdau, V., Kerr, W. J. & Reid, M. Deuterium- and tritium-labelled compounds: applications in the life sciences. Angew. Chem. Int. Ed. 57, 1758–1784 (2018).
Miller, P. W., Long, N. J., Vilar, R. & Gee, A. D. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew. Chem. Int. Ed. 47, 8998–9033 (2008).
Elmore, C. S. & Bragg, R. A. Isotope chemistry; a useful tool in the drug discovery arsenal. Bioorg. Med. Chem. Lett. 25, 167–171 (2015).
Bar-Shalom, R., Valdivia, A. Y. & Blaufox, M. D. PET imaging in oncology. Semin. Nucl. Med. 30, 150–185 (2000).
Tiepolt, S. et al. Current radiotracers to image neurodegenerative diseases. EJNMMI Radiopharm. Chem. 4, 17 (2019).
Suridjan, I., Comley, R. A. & Rabiner, E. A. The application of positron emission tomography (PET) imaging in CNS drug development. Brain Imaging Behav. 13, 354–365 (2019).
Piel, M., Vernaleken, I. & Rösch, F. Positron emission tomography in CNS drug discovery and drug monitoring. J. Med. Chem. 57, 9232–9258 (2014).
Boscutti, G., Huiban, M. & Passchier, J. Use of carbon-11 labelled tool compounds in support of drug development. Drug Discov. Today Technol. 25, 3–10 (2017).
Hargreaves, R. Imaging substance P receptors (NK1) in the living human brain using positron emission tomography. J. Clin. Psychiat. 63, 18–24 (2002).
Deng, X. et al. Chemistry for positron emission tomography: recent advances in 11C-, 18F-, 13N-, and 15O-labeling reactions. Angew. Chem. Int. Ed. 58, 2580–2605 (2019).
Dahl, K., Halldin, C. & Schou, M. New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals. Clin. Transl. Imaging 5, 275–289 (2017).
Zarate, C., Yang, H., Bezdek, M. J., Hesk, D. & Chirik, P. J. Ni(i)–X complexes bearing a bulky α-diimine ligand: synthesis, structure, and superior catalytic performance in the hydrogen isotope exchange in pharmaceuticals. J. Am. Chem. Soc. 141, 5034–5044 (2019).
Voges, R., Heys, J. R. & Moenius, T. Preparation of tritium-labeled compounds by chemical synthesis. In Preparation of Compounds Labeled with Tritium and Carbon‐14 109–209 (John Wiley & Sons, 2009).
Wuest, F., Berndt, M. & Kniess, T. Carbon-11 labeling chemistry based upon [11C]methyl iodide. In PET Chemistry (eds Schubiger, P. A., Lehmann, L. & Friebe, M.) 183–213 (Springer, 2007).
McGrath, N. A., Brichacek, M. & Njardarson, J. T. A graphical journey of innovative organic architectures that have improved our lives. J. Chem. Educ. 87, 1348–1349 (2010).
Voges, R., Heys, J. R. & Moenius, T. Introduction. In Preparation of Compounds Labeled with Tritium and Carbon‐14 1–23 (John Wiley & Sons, 2009).
Sandell, J. et al. Synthesis, radiolabeling and preliminary biological evaluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter. Bioorg. Med. Chem. Lett. 12, 3611–3613 (2002).
Halldin, C. et al. Development of a central nicotinic acetylcholine receptor radioligand, 5-methyl-A-85380, and postmortem autoradiography in human brain. J. Labelled Comp. Radiopharm. 44, S251–S253 (2001).
Twilton, J. et al. The merger of transition metal and photocatalysis. Nat. Rev. Chem. 1, 0052 (2017).
Zhang, P. & Le, C. & MacMillan, D. W. C. Silyl radical activation of alkyl halides in metallaphotoredox catalysis: a unique pathway for cross-electrophile coupling. J. Am. Chem. Soc. 138, 8084–8087 (2016).
Smith, R. T. et al. Metallaphotoredox-catalyzed cross-electrophile Csp3–Csp3 coupling of aliphatic bromides. J. Am. Chem. Soc. 140, 17433–17438 (2018).
Li, P. & Olszewski, J. D. Radiosynthesis of [3H]-ABP688 using [3H]-methyl nosylate: a non-volatile alternative methylating agent. J. Labelled Comp. Radiopharm. 52, 512–513 (2009).
Le, C. et al. A general small-scale reactor to enable standardization and acceleration of photocatalytic reactions. ACS Cent. Sci. 3, 647–653 (2017).
Smith, J. R. L. & Masheder, D. Amine oxidation. Part IX. The electrochemical oxidation of some tertiary amines: the effect of structure on reactivity. J. Chem. Soc. Perkin Trans. 2, 47–51 (1976).
Koyama, H. et al. Synthesis of PET probe O6-[(3-[11C]methyl)benzyl]guanine by Pd0-mediated rapid C-[11C]methylation toward imaging DNA repair protein O6-methylguanine-DNA methyltransferase in glioblastoma. Bioorg. Med. Chem. Lett. 27, 1892–1896 (2017).
Nabulsi, N. B. et al. Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain. J. Nucl. Med. 57, 777–784 (2016).
Shimoda, Y. et al. Synthesis and evaluation of novel radioligands based on 3-[5-(pyridin-2-yl)-2H-tetrazol-2-yl]benzonitrile for positron emission tomography imaging of metabotropic glutamate receptor subtype 5. J. Med. Chem. 59, 3980–3990 (2016).
Hostetler, E. D., Fallis, S., McCarthy, T. J., Welch, M. J. & Katzenellenbogen, J. A. Improved methods for the synthesis of [ω-11C]palmitic acid. J. Org. Chem. 63, 1348–1351 (1998).
Shoup, T. M. et al. Synthesis of the dopamine D2/D3 receptor agonist (+)-PHNO via supercritical fluid chromatography: preliminary PET imaging study with [3-11C]-(+)PHNO. Tetrahedr. Lett. 55, 682–685 (2014).
Andries, J., Lemoine, L., Le Bars, D., Zimmer, L. & Billard, T. Synthesis and biological evaluation of potential 5-HT7 receptor PET radiotracers. Eur. J. Med. Chem. 46, 3455–3461 (2011).
Mintun, M. A. et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67, 446–452 (2006).
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Quality Guidelines https://www.ich.org/page/quality-guidelines.
Isin, E. M., Elmore, C. S., Nilsson, G. N., Thompson, R. A. & Weidolf, L. Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies. Chem. Res. Toxicol. 25, 532–542 (2012).
Gant, T. G. Using deuterium in drug discovery: leaving the label in the drug. J. Med. Chem. 57, 3595–3611 (2014).
Atzrodt, J., Derdau, V., Fey, T. & Zimmermann, J. The renaissance of H/D exchange. Angew. Chem. Int. Ed. 46, 7744–7765 (2007).
Acknowledgements
Research reported in this publication was supported by the NIH (under award number R35GM134897-01) and the Princeton Catalysis Initiative. We thank L. Wilson (Lotus Separations) and H. Wang for compound purification; I. Mergelsberg, M. Reibarkh and Y. N. J. Chen for discussions; A. Chaudhary and Z. Zhu (Siemens) for high-activity [11C]UCB-J radiotracer synthesis; and C. Liu for assistance in preparing this manuscript.
Author information
Authors and Affiliations
Contributions
P.Z.M., S.R., T.J.A.G., D.H., E.D.H., I.W.D. and D.W.C.M. conceived the work. R.W.P., P.Z.M. and S.R. conducted initial optimization. R.W.P., K.T.S. and S.R. synthesized organobromide precursors. R.W.P. and K.T.S. performed and isolated labelling experiments. R.W.P., K.T.S., S.R. and D.H. developed purification conditions. T.J.A.G., S.V. and E.D.H. provided insight into experimental design. L.G. conducted the non-human primate PET imaging study and T.G.L. performed data analysis. A.S. configured and performed the fully automated radiosynthesis and H.S.L. performed data analysis. R.W.P., K.T.S., T.J.A.G. and D.W.C.M. prepared the manuscript with input from all co-authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information Nature thanks Yu-Shin Ding and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
This file contains Supplementary Materials and Methods, Supplementary Text, Supplementary Figures S1–S17, NMR Spectra, and Supplementary References.
Supplementary Video 1
: Photoreactor Initiation for Automated Radiosynthesis A brief video demonstrating how the integrated photoreactor is switched on with a Bluetooth-enabled, SwitchBot remote control push button for application to automated carbon-11 radiolabeling.
Rights and permissions
About this article
Cite this article
Pipal, R.W., Stout, K.T., Musacchio, P.Z. et al. Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery. Nature 589, 542–547 (2021). https://doi.org/10.1038/s41586-020-3015-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-020-3015-0
This article is cited by
-
Multi-carbon labelling of active pharmaceutical ingredients enabled by a three-gas surrogate hydroformylation
Nature Synthesis (2023)
-
Radiochemistry for positron emission tomography
Nature Communications (2023)
-
[18F]Difluorocarbene for positron emission tomography
Nature (2022)
-
Recyclable cooperative catalyst for accelerated hydroaminomethylation of hindered amines in a continuous segmented flow reactor
Nature Communications (2022)
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.